A solution so smart, you'll wonder why no one thought of it until now.

When sites source drugs and supplies independently, the result is often a chaotic process that wastes time and money, complicates billing and administration, and causes disruption to your trial. That’s why Myoderm created CentralSource – a revolutionary turn-key service that centralizes NIMP drug sourcing, distribution, and inventory management for clinical trials.


With CentralSource, all the drugs and supplies your sites require, including NIMPs and standard-of-care medications, are sourced and then consolidated at our state-of-the-art distribution facility. Each of your sites is then directly supplied on an ongoing, as-needed basis using cutting-edge technology that streamlines planning, procurement, and management.